Abstract
Intranasal administration of basic fibroblast growth factor prevented or reduced oligokinesia, muscular rigidity, and weight loss and also prevented mortality in mice with parkinsonism induced by repetitive intraperitoneal injections of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine. These beneficial effects are probably due to trophic actions of the factor, whereby the degeneration of nigrostriatal neurons is weakened and delayed and their survival is prolonged.
Similar content being viewed by others
References
G. N. Kryzhanovskii, V. G. Kucheryanu, L. S. Godlevskii, and A. D. mazarati,Byull. Eksp. Biol. Med.,113, No 1, 16–19 (1992).
B. Cheng and M. P. Mattson,Neuron,7, 1031–1041 (1991).
D. H. Damon,J. Cell Physiol.,138, 221–226 (1989).
I. Date, M. F. D. Notter, S. Y. Felten, and D. L. Felten,Brain Res.,526, 156–160 (1990).
F. Fefti, J. Hartikka, and B. Knusell,Neurobiol. Aging,10, 515–533 (1989).
A. Frese, S. Finkelstein, and M. Di Figlia,Brain Res.,575, 351–355 (1992).
O. Hornykiewicz and S. J. Kish,Adv. Neurol.,45, 19–34 (1986).
B. Knusell,J. Neurosci.,10, No 2, 558–570 (1990).
A. Logan, S. A. Frautschly, A.-M. Gonzalez, and A. Daird,J. Neurosci.,12, No 10, 3828–3837 (1992).
D. J. Otto,J. Neurosci.,10, 1912–1921 (1990).
R. C. Roberts, C. G. Landay, S. P. Finkelstein, and M. Di Figlia,Soc. Neurosci. Abstr.,16, 1231 (1990).
K. Uniickez, S. Engels, and C. Hamm,Ann. Anat.,174, No 5, 405–407 (1992).
D. Zhou and M. Di Figlia,Soc. Neurosci. Abstr.,17, 857 (1991).
Author information
Authors and Affiliations
Additional information
Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 120, No 9, pp. 260–262, September, 1995
Rights and permissions
About this article
Cite this article
Kryzhanovskii, G.N., Kucheryanu, V.G., Nikushkin, E.V. et al. Influence of basic fibroblast growth factor on the development of parkinsonian syndrome in mice. Bull Exp Biol Med 120, 900–902 (1995). https://doi.org/10.1007/BF02445010
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02445010